2Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes [ J ]. Diabetes Care,2004,27 : 1535 - 1540.
3Turner RC,Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus[J]. JAMA,1999,281:2005 -2012.
4Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes : a consensus algorithm for the initiation and adjustment of therapy [ J ]. Diabetes Care, 2006,29 : 1963 - 1972.
5Chan JCN, Deerochanawong C, Samad SA ,et al. Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian- Pacific perspective[J]. Diabetes Res Clin Pract, 2007,75 : 255 - 266.
6Van Gaal LF, De Leeuw IH. Rationale and options for combination therapy in the treatment of type 2 diabetes [ J ]. Diabetologia, 2003,46 ( suppl 1 ) : M44 - M50.
7Wright A, Burden ACF, Paisey RB, et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK. Prospective Diabetes Study( UKPDS 57) [J]. Diabetes Care ,2002,25:330 - 336.
8Riddle MC, Rosenstock J, Gerich J, et al. The treat-to-target trial randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients [ J ]. Diabetes Care,2003,26 ( 11 ) : 3080 - 3086.
9Janka HU, Plewe G, Riddle MC, et al. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes [ J ]. Diabetes Care,2005, 28:254 - 259.
10Vinik A. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy [ J ]. Clin Ther,2007,29 : 1236 - 1253.
